• Geneticin: From Selection to Translational Strategy

  2026-08-31

  Geneticin and G418 Sulfate are more than routine selection reagents. Their translation-level mechanism, resistance-marker dependence, and emerging antiviral profile make them valuable tools for designing reproducible cell models and interpreting complex cancer and virology experiments.

• Etomoxir and the Translational Logic of Immunometabolism

  2026-08-30

  Etomoxir offers a practical way to interrogate fatty acid oxidation at the interface of mitochondrial metabolism, immune activation, and disease biology. This thought-leadership guide connects CPT-1 mechanism with standardized whole-blood assays, EAE research, experimental controls, and translational decision-making.

• Palmitic acid: Protocol and QC Guidance

  2026-08-29

  Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a characterized saturated long-chain fatty acid for controlled studies of lipid metabolism, metabolic disorder research, inflammation signaling, and protein palmitoylation. It is not appropriate for aqueous-only workflows or long-term storage as a solution, so solvent selection, reconstitution, and vehicle controls are central to reproducibility.

• PRMT5 Splicing Vulnerability in MYCN Neuroblastoma

  2026-08-28

  The reference study identifies a MYCN-dependent vulnerability in neuroblastoma that links PRMT5-controlled RNA splicing to epitranscriptomic regulation and disrupted glutamine metabolism. Its integrated transcriptomic, metabolic-tracing, and in vivo data suggest that spliceosomal control of GLS protein expression helps determine sensitivity to PRMT5 inhibition, providing a mechanistic framework for cancer metabolism research and preclinical cancer drug evaluation.

• Degarelix acetate: GnRH Antagonist Workflows

  2026-08-28

  Build reproducible receptor-binding, hormone-secretion, and long-duration endocrine studies with Degarelix acetate. Its rapid GnRH blockade supports prostate cancer research while the reference goat study shows how repeated dosing can connect molecular assays with functional reproductive endpoints.

• Plk1 Control of p31comet in MCC Disassembly

  2026-08-28

  This PNAS study identifies Polo-like kinase 1 (Plk1) as a regulator that restrains p31comet-mediated disassembly of mitotic checkpoint complexes. By combining HeLa cell extracts, selective kinase inhibition, purified proteins, phosphorylation analysis, and an S102A mutant, the authors show how Plk1 phosphorylation may prevent premature checkpoint silencing during mitosis.

• Multiplexed ACE2 Libraries Map SARS-CoV-2 Receptor Shifts

  2026-08-27

  Shukla and colleagues developed a barcoded pseudotyped-virus assay that measures how multiple ACE2 sequences support entry by SARS-CoV-2 spike variants in parallel. Their results show relatively modest changes in human ACE2 usage but substantially more diverse, variant-specific compatibility across animal ACE2 orthologs, providing a scalable framework for studying host-range evolution.

• Ouabain: Selective Na+/K+-ATPase Inhibitor

  2026-08-26

  Ouabain is a cell-impermeable, selective Na+/K+-ATPase inhibitor that disrupts sodium and potassium gradients and can secondarily alter calcium handling through NCX. Its defined cellular and animal-model benchmarks support Na+/K+-ATPase inhibition assays, cardiovascular research, and mechanistic studies of ion transport.

• RNA Pol II Inhibition and Active Apoptotic Signaling

  2026-08-26

  Harper et al. show that RNA polymerase II inhibition induces apoptosis through an active signaling process triggered by loss of hypophosphorylated RNA Pol IIA, rather than through passive depletion of transcripts and proteins. Their PDAR model links RNA Pol II degradation to mitochondrial death signaling and helps explain why mechanistically diverse drugs can share a common lethal mechanism.

• Epacadostat (INCB024360): IDO1 Research Guide

  2026-08-25

  Epacadostat, also called INCB024360, is an orally active, selective IDO1 inhibitor for studying tryptophan–kynurenine metabolism and tumor immune suppression. Product-reported potency, physicochemical properties, and preclinical use support its application in enzymatic, cellular, whole-blood, and combination immuno-oncology research.

• P2Y11 Antagonist NF 340: Assay Workflows

  2026-08-24

  NF 340 gives researchers a receptor-level way to test how P2Y11 signaling contributes to breast-cancer cell invasion, myosin light-chain phosphorylation, and broader inflammation pathway modulation. This guide translates the reference study into practical treatment, invasion-assay, control, and troubleshooting workflows while defining the limits of extrapolation to immunology research.

• Carbenoxolone disodium: Practical Lab Guide

  2026-08-24

  Carbenoxolone disodium provides a practical pharmacological perturbation for studying 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, and gap junction communication in cell and tissue workflows. It is best used with vehicle, viability, and orthogonal controls, and should not be treated as a selective probe or as evidence for in vivo efficacy.

• Angiotensin 1/2 (5-7): Assay Reliability

  2026-08-23

  This scenario-driven guide shows how Angiotensin 1/2 (5-7), SKU A1049, can support better-controlled viability, proliferation, cytotoxicity, and renin–angiotensin system experiments. It combines product specifications, solvent and storage guidance, and recent evidence on angiotensin-peptide modulation of SARS-CoV-2 spike-protein binding.

• Optimized hiPSC Platelet Differentiation: Study Insights

  2026-08-22

  This 2026 study presents an optimized embryoid body-based workflow for producing functional platelets from human induced pluripotent stem cells. By increasing starting cell input, replacing selected cytokines with small molecules, using human platelet lysate, and improving megakaryocyte maturation, the protocol increases output, shortens culture time, and lowers estimated production costs.

• Epalrestat Workflows for Neuroprotection Research

  2026-08-21

  Epalrestat combines aldose reductase inhibition with a research route into KEAP1/Nrf2 signaling, making it useful for integrated polyol pathway, mitochondrial, and oxidative stress studies. This guide translates published Parkinson’s disease model findings into practical cell, mouse, formulation, and troubleshooting workflows.

446 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page